dibenzylidene acetone has been researched along with Colonic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aggarwal, BB; Prasad, S; Ravindran, J; Yadav, VR | 1 |
1 other study(ies) available for dibenzylidene acetone and Colonic Neoplasms
Article | Year |
---|---|
ROS and CHOP are critical for dibenzylideneacetone to sensitize tumor cells to TRAIL through induction of death receptors and downregulation of cell survival proteins.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Down-Regulation; Drug Synergism; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; HCT116 Cells; HT29 Cells; Humans; Mitogen-Activated Protein Kinases; Pentanones; PPAR gamma; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Receptors, Death Domain; TNF-Related Apoptosis-Inducing Ligand; Transcription Factor CHOP; Tumor Necrosis Factor Decoy Receptors; Up-Regulation | 2011 |